Amit Verma, MD
Internal Medicine · Dallas, TXNPI 1033299524
Payments from drug & device makers
Across 177 payments — averaging $43,650 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$6.1M
- Janssen Research & Development, LLC$1.2M
- Bristol Myers Squibb$156K
- Pfizer$100K
- Otsuka Pharmaceutical Co., Ltd.$59K
- Takeda Pharmaceuticals U.S.A., Inc.$36K
- plus $130K from 15 others
Across 8 payments — averaging $2126.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$10K
- Pfizer$7K
What the payments were for
- Consulting fees$46,01387%
- Speaking & faculty fees$1,2702%
- Travel & lodging$5671%
- Food & beverage$4501%
- Education$4,6719%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 7 | $6,070,263 |
| Janssen Research & Development, LLC | 13 | $1,175,871 |
| Bristol Myers Squibb | 16 | $155,510 |
| Pfizer | 35 | $99,669 |
| Otsuka Pharmaceutical Co., Ltd. | 10 | $58,533 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $35,846 |
| E.r. Squibb & Sons, L.L.C. | 3 | $33,131 |
| Bayer | 24 | $32,028 |
| Genentech, Inc. | 10 | $23,969 |
| F. Hoffmann-la Roche AG | 5 | $16,257 |
| Gilead(2 entities) | 12 | $15,848 |
| Eli Lilly | 1 | $6,112 |
| Astrazeneca UK Limited | 1 | $2,740 |
| Geron Corporation | 3 | $143 |
| Medtronic | 1 | $41 |
| Deciphera Pharmaceuticals Inc. | 1 | $27 |
| AstraZeneca | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $15 |
| Sanofi | 1 | $12 |
| Incyte Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,726,065 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Dallas
- Valentine EbuhDallas$6.8M
- Gary SinclairDallas$3.4M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.